Products 366017-09-6

CAS 366017-09-6 appears in our catalog under these names: Mubritinib/ 99.87% (existing batch purity), Mubritinib (TAK 165), Mubritinib, >98.0%(HPLC), Mubritinib, Mubritinib 98%. Offered by: TargetMol, GLPBio, TCI, Biosynth, Ambeed. Available pack sizes: 5mg, 10mg, 25mg, 50mg, 100mg, 200mg, 10mM/1mL, 25 mg.

Structural formula: {0} (CAS {1})

Mubritinib has been used in trials studying the treatment of Lung Neoplasm, Renal Neoplasm, Breast Neoplasm, Ovarian Neoplasm, and Pancreatic Neoplasm.

Source: ChEBI

Identity
Molecular formulaC25H23F3N4O2
Molecular weight468.5 g/mol
IUPAC name4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole
InChIKeyZTFBIUXIQYRUNT-MDWZMJQESA-N
SMILESC1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)/C=C/C4=CC=C(C=C4)C(F)(F)F

Computed by PubChem (NCBI)